NASDAQ:PGEN

Precigen Stock Insider Trading

Healthcare > Biotechnology

Buy PGEN

*Your capital is at risk

$3.81

-0.0500 (-1.30%)

At Close: Jun 03, 2026

Precigen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -70.98. In total, the insiders bought 8.48M and sold 6.89M PGEN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-70.98
● Buy	8.48M shares
● Sell	6.89M shares
75% Buy Activity Strong Negative Correlation
Buy Signal Low Confidence Apr 20, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -70.98. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 28, 2026 Sell	Common Stock S-Sale	Sabzevari Helen President And CEO	CEO / President	119 250 Value: $519.9K
May 28, 2026 Sell	Common Stock S-Sale	Lehr Donald P. Chief Legal Officer	Officer	29 131 Value: $127.0K
May 28, 2026 Sell	Common Stock S-Sale	Thomasian Harry Jr. Chief Financial Officer	C-Suite Officer	41 884 Value: $182.6K
May 28, 2026 Sell	Common Stock S-Sale	Tennant Phil Chief Commercial Officer	Officer	30 272 Value: $132.0K
May 28, 2026 Sell	Common Stock S-Sale	Shah Rutul R Chief Operating Officer	C-Suite Officer	42 703 Value: $186.2K
May 23, 2026 Buy	Restricted Stock Units M-Exempt	Lehr Donald P. Chief Legal Officer	Officer	62 500 Value: $238.1K
May 23, 2026 Buy	Common Stock M-Exempt	Lehr Donald P. Chief Legal Officer	Officer	62 500 Value: $238.1K
May 23, 2026 Buy	Restricted Stock Units M-Exempt	Shah Rutul R Chief Operating Officer	C-Suite Officer	90 000 Value: $342.9K
May 23, 2026 Buy	Common Stock M-Exempt	Shah Rutul R Chief Operating Officer	C-Suite Officer	90 000 Value: $342.9K
May 23, 2026 Buy	Restricted Stock Units M-Exempt	Tennant Phil Chief Commercial Officer	Officer	62 500 Value: $238.1K
May 23, 2026 Buy	Common Stock M-Exempt	Thomasian Harry Jr. Chief Financial Officer	C-Suite Officer	87 500 Value: $333.4K
May 23, 2026 Buy	Restricted Stock Units M-Exempt	Thomasian Harry Jr. Chief Financial Officer	C-Suite Officer	87 500 Value: $333.4K
May 23, 2026 Buy	Common Stock M-Exempt	Tennant Phil Chief Commercial Officer	Officer	62 500 Value: $238.1K
May 23, 2026 Buy	Common Stock M-Exempt	Sabzevari Helen President And CEO	CEO / President	250 000 Value: $952.5K
May 23, 2026 Buy	Restricted Stock Units M-Exempt	Sabzevari Helen President And CEO	CEO / President	250 000 Value: $952.5K
Apr 20, 2026 Buy	Restricted Stock Units A-Award	Thomasian Harry Jr. Chief Financial Officer	C-Suite Officer	120 000 Value: $493.2K
Apr 20, 2026 Buy	Option to Purchase Common Stock (Right to Buy) A-Award	Thomasian Harry Jr. Chief Financial Officer	C-Suite Officer	399 000 Value: $1.64M
Apr 20, 2026 Buy	Restricted Stock Units A-Award	Shah Rutul R Chief Operating Officer	C-Suite Officer	118 000 Value: $485.0K
Apr 20, 2026 Buy	Option to Purchase Common Stock (Right to Buy) A-Award	Shah Rutul R Chief Operating Officer	C-Suite Officer	395 000 Value: $1.62M
Apr 20, 2026 Buy	Restricted Stock Units A-Award	Sabzevari Helen President And CEO	CEO / President	410 000 Value: $1.69M
Apr 20, 2026 Buy	Option to Purchase Common Stock (Right to Buy) A-Award	Sabzevari Helen President And CEO	CEO / President	1 366 000 Value: $5.61M
Apr 20, 2026 Buy	Option to Purchase Common Stock (Right to Buy) A-Award	Lehr Donald P. Chief Legal Officer	Officer	358 000 Value: $1.47M
Apr 20, 2026 Buy	Restricted Stock Units A-Award	Lehr Donald P. Chief Legal Officer	Officer	107 000 Value: $439.8K
Apr 20, 2026 Buy	Option to Purchase Common Stock (Right to Buy) A-Award	Tennant Phil Chief Commercial Officer	Officer	385 000 Value: $1.58M
Apr 20, 2026 Buy	Restricted Stock Units A-Award	Tennant Phil Chief Commercial Officer	Officer	115 000 Value: $472.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT PRECIGEN, INC.

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic comp...

Read Full Profile Here